Skip to main content
Caplight Logo









Koka Lifesciences

Koka Lifesciences

Private
NantongHealthcare & Life Scienceshttp://kokalife.com/

Last Round

Early Funding

Oct 8, 2021

Total Funding Raised

$54.7M

Company Overview

Koka Lifesciences is a medical device company that develops and manufactures interventional heart valve devices for the treatment of structural heart diseases.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical deviceinterventional cardiologyheart valvecardiovascular implantstructural heart diseasemedtechpharmaceutical formulationnutraceuticalmedical equipmenthealth supplementpharma distributionmedical supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Koka Lifesciences Comparables

Compare Koka Lifesciences with similar companies based on industry and business-model similarity.

Koka Lifesciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lepu Medical Technology
41%
Nanjing Saint Medical Technology Co., Ltd.
39%
Shanghai Hanyu Medical Technology
34%

Koka Lifesciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 8, 2021
Series BNov 27, 2020
Series ASep 1, 2019

Koka Lifesciences Investors

Notable investors and investment history

Koka Lifesciences investors
InvestorRounds
Jifeng VenturesSeries B
Zheshang Venture CapitalSeries B
China Zhongji InvestmentEarly Funding
CAS StarSeries A
Blue Ocean Capital GroupEarly Funding
Sherpa CapitalSeries B
华创资本Series A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 8, 2021

    $55M raised led by Blue Ocean Capital Group.

  • Nov 27, 2020

    Raised Series B with investors including Sherpa Capital and Jifeng Ventures.

Koka Lifesciences Filings

Explore SEC and related filing metadata, where available.

Koka Lifesciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Koka Lifesciences's valuation, stock price, and market status.

Is Koka Lifesciences a public or private company?

Koka Lifesciences is a private company.

What is the current stock price of Koka Lifesciences?

Koka Lifesciences is a private company with no public stock price. Caplight tracks Koka Lifesciences's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Koka Lifesciences worth (valuation)?

Valuation information for Koka Lifesciences is not publicly available.

Can I buy Koka Lifesciences stock?

Koka Lifesciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Koka Lifesciences's last funding round?

Koka Lifesciences's most recent funding round was Early Funding on October 8, 2021.

Who are the main investors in Koka Lifesciences?

Key investors in Koka Lifesciences include Blue Ocean Capital Group.

Will Koka Lifesciences IPO soon?

No public IPO plans have been announced for Koka Lifesciences.

How can I track Koka Lifesciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Koka Lifesciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNantong
Year Founded2018
Last FundingOct 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?